title: Medical devices; exception from general requirements for informed consent. Final rule.
abstract: The Food and Drug Administration (FDA) is issuing a final regulation to confirm, with one change, the interim final rule (IFR) entitled "Medical Devices; Exception From General Requirements for Informed Consent." This final rule confirms the IFR's establishment of a new exception from the general requirements for informed consent to permit the use of investigational in vitro diagnostic devices to identify chemical, biological, radiological, or nuclear agents without informed consent in certain circumstances. FDA has created this exception to help ensure that individuals who may have been exposed to a chemical, biological, radiological, or nuclear agent are able to benefit from the timely use of the most appropriate diagnostic devices, including those that are investigational. This final rule adds a requirement that the investigator submit the required documentation to FDA, in addition to submitting it to the reviewing Institutional Review Board (IRB).
mesh_terms: D002624:Chemistry, Clinical / Q000331:legislation & jurisprudence*; D019937:Diagnostic Techniques and Procedures / Q000295:instrumentation*; D004630:Emergencies; D004635:Emergency Medicine / Q000295:instrumentation* / Q000331:legislation & jurisprudence; D004781:Environmental Exposure; D006801:Humans; D007258:Informed Consent / Q000331:legislation & jurisprudence*; D011933:Reagent Kits, Diagnostic; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D011933:Reagent Kits, Diagnostic